dr. polsky on validating ctdna as a biomarker in braf-mutant melanoma
Published 4 years ago • 32 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
1:13
dr. polsky on using ctdna as a biomarker for melanoma
-
2:06
dr. polsky on the predictive value of ctdna in braf-mutant melanoma
-
1:02
dr. polsky on the clinical validity of ctdna in braf-mutant melanoma
-
0:57
dr. polsky on potential applications of ctdna in melanoma
-
1:12
dr. polsky on the association between ctdna and survival in melanoma
-
20:34
role of circulating tumor cells/dna & liquid biopsy in melanoma - david polsky
-
2:03
analysis demonstrates correlation between presence of ctdna and survival in melanoma
-
1:00
dr. blachly discusses ctdna as a biomarker in hairy cell leukemia
-
28:57
circulating tumor dna as an immunotherapy biomarker
-
2:46
recommendations for molecular testing in melanoma
-
0:55
dr. polsky on the unmet need of clinical utility in liquid biopsy
-
0:59
how physicians can detect ctdna in melanoma
-
1:15
biomarkers being explored in hodgkin lymphoma: the role of ctdna
-
0:42
ctdna in clinical practice for melanoma
-
40:35
biomarkers lighting the way
-
0:58
real-world monitoring of circulating tumor dna to predict cancer recurrence
-
1:25
moffitt medical minute - circulating tumor dna (ep. 9)
-
1:09
ctdna mrd as a biomarker for solid tumors
-
3:44
ctdna as a diagnostic, prognostic, and predictive biomarker for lung cancer